Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. Receive News & Ratings for argenx Daily - ...

Co-founder Jim Dias and inaugural member Harold Boyden both saw their jerseys retired following the tournament, though both ...